![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Kammy KS Poon & Steven HS Wong. (2017) New and developing anesthesia drugs. Expert Opinion on Pharmacotherapy 18:2, pages 195-204.
Read now
Read now
Srinath Muppalaneni, David J. Mastropietro & Hossein Omidian. (2016) Crush resistance and insufflation potential of poly(ethylene oxide)-based abuse deterrent formulations. Expert Opinion on Drug Delivery 13:10, pages 1375-1382.
Read now
Read now
Roshan V. Tiwari, Hemlata Patil & Michael A. Repka. (2016) Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opinion on Drug Delivery 13:3, pages 451-464.
Read now
Read now
Tiffani D. Eisenhauer, Mike Matchett, Ralph Heasley, Terri Morton, Krishna Devarakonda, Michael Giuliani, Jim L. Young & Thomas Barrett. (2016) Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug Development and Industrial Pharmacy 42:1, pages 157-165.
Read now
Read now
Krishna Devarakonda, Kenneth Kostenbader, Yanping Zheng, Jeannie B. Montgomery, Thomas Barrett, Jim L. Young & Lynn R. Webster. (2015) Human abuse potential of immediate-release/extended-release versus immediate-release hydrocodone bitartrate/acetaminophen: a randomized controlled trial in recreational users of prescription opioids. Postgraduate Medicine 127:1, pages 13-21.
Read now
Read now
Charles E. Argoff & Ernest A. Kopecky. (2014) Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options. Current Medical Research and Opinion 30:12, pages 2543-2559.
Read now
Read now
Terri Morton, Kenneth Kostenbader, Jeannie Montgomery, Krishna Devarakonda, Thomas Barrett & Lynn Webster. (2014) Comparison of Subjective Effects of Extended-Release Versus Immediate-Release Oxycodone/Acetaminophen Tablets in Healthy Nondependent Recreational Users of Prescription Opioids: A Randomized Trial. Postgraduate Medicine 126:4, pages 20-32.
Read now
Read now
Charles E Argoff, Steven P Stanos & Matthew S Wieman. (2013) Validity testing of patient objections to acceptance of tamper-resistant opioid formulations. Journal of Pain Research 6, pages 367-373.
Read now
Read now
Jeffrey A. Gudin. (2013) Assessment of Extended-Release Opioid Analgesics for the Treatment of Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy 27:1, pages 49-61.
Read now
Read now
Steven Stanos. (2012) Evolution of Opioid Risk Management and Review of the Classwide REMS for Extended-Release/Long-Acting Opioids. The Physician and Sportsmedicine 40:4, pages 12-20.
Read now
Read now
Eugene R. Viscusi. (2012) A Response to Seed et al, Regarding Choices of New Opioid Formulations. Hospital Practice 40:4, pages 64-65.
Read now
Read now
Marco Pappagallo & Marta Sokolowska. (2012) The Implications of Tamper–Resistant Formulations for Opioid Rotation. Postgraduate Medicine 124:5, pages 101-109.
Read now
Read now
Articles from other publishers (30)
Golam Kibria, Bandaranayake Bandaranayake, Jiwen Zheng, Sau Lee & Celia Cruz. (2023) Stability of Abuse-deterrent properties of PEO-based Abuse-deterrent formulation. International Journal of Pharmaceutics 631, pages 122430.
Crossref
Crossref
Dongyue Yu, Raghunadha Reddy Seelam, Feng Zhang, Stephen R. Byrn & Stephen W. Hoag. (2021) Evaluation of tableting performance of Poly (ethylene oxide) in abuse-deterrent formulations using compaction simulation studies. Journal of Pharmaceutical Sciences 110:7, pages 2789-2799.
Crossref
Crossref
Arun Butreddy, Sandeep Sarabu, Nagireddy Dumpa, Suresh Bandari & Michael A. Repka. (2020) Extended release pellets prepared by hot melt extrusion technique for abuse deterrent potential: Category-1 in-vitro evaluation. International Journal of Pharmaceutics 587, pages 119624.
Crossref
Crossref
Heather J. Boyce, Vivek S. Dave, Myke Scoggins, Vadim J. Gurvich, Daniel T. Smith, Stephen R. Byrn & Stephen W. Hoag. (2020) Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic
Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo
Tablets. AAPS PharmSciTech 21:3.
Crossref
Crossref
Saikishore Meruva & Maureen D. Donovan. (2019) Polyethylene Oxide (PEO) Molecular Weight Effects on Abuse-Deterrent Properties of Matrix Tablets. AAPS PharmSciTech 21:1.
Crossref
Crossref
Elizabeth Tocce, Matthew Bishop, Karen Balwinski, Tom Watson, Mike Lapham, Kathryn Hewlett & Alexis Wontorcik. (2019) Mechanical Characterization of Thermally Annealed Tablets
Containing Polyethylene Oxide for Abuse Deterrence. AAPS PharmSciTech 21:1.
Crossref
Crossref
Jan Kozak, Miloslava Rabiskova & Alf Lamprecht. (2019) Silk Fibroin as a Novel Alcohol-Resistant Excipient for Sustained-Release Tablet Formulation. AAPS PharmSciTech 20:7.
Crossref
Crossref
Xiaoming Xu, Akhtar Siddiqui, Charudharshini Srinivasan, Adil Mohammad, Ziyaur Rahman, Maxwell Korang-Yeboah, Xin Feng, Mansoor Khan & Muhammad Ashraf. (2019) Evaluation of Abuse-Deterrent Characteristics of Tablets
Prepared via Hot-Melt Extrusion. AAPS PharmSciTech 20:6.
Crossref
Crossref
Yangmei Ren, Lan Mei, Liangxue Zhou & Gang Guo. (2019) Recent Perspectives in Hot Melt Extrusion-Based Polymeric Formulations for Drug Delivery: Applications and Innovations. AAPS PharmSciTech 20:3.
Crossref
Crossref
Saikishore Meruva & Maureen D. Donovan. (2019) Effects of Drug-Polymer Interactions on Tablet Properties During
the Development of Abuse-Deterrent Dosage Forms. AAPS PharmSciTech 20:3.
Crossref
Crossref
Xin Feng & Feng Zhang. (2017) Twin-screw extrusion of sustained-release oral dosage forms and medical implants. Drug Delivery and Translational Research 8:6, pages 1694-1713.
Crossref
Crossref
James DiNunzioSeth ForsterChad Brown. 2017. Concise Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Concise Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
827
844
.
Stephen R Byrn, George Zografi & Xiaoming Sean Chen. 2017. Solid State Properties of Pharmaceutical Materials. Solid State Properties of Pharmaceutical Materials
351
374
.
B. Chen, L. Zhu, F. Zhang & Y. Qiu. 2017. Developing Solid Oral Dosage Forms. Developing Solid Oral Dosage Forms
821
868
.
Julien Maincent & Feng Zhang. (2016) Recent advances in abuse-deterrent technologies for the delivery of opioids. International Journal of Pharmaceutics 510:1, pages 57-72.
Crossref
Crossref
Charlie Martin. (2016) Twin Screw Extruders as Continuous Mixers for Thermal Processing: a Technical and Historical Perspective. AAPS PharmSciTech 17:1, pages 3-19.
Crossref
Crossref
James DiNunzio, Seth Forster & Chad Brown. 2015. Handbook of Encapsulation and Controlled Release. Handbook of Encapsulation and Controlled Release
1127
1150
.
Xiaofan Li, Daryl Shorter & Thomas Kosten. (2015) Prescription Opioid Misuse: Effective Methods for Reducing the Epidemic. Current Treatment Options in Psychiatry 2:2, pages 122-135.
Crossref
Crossref
Jeffrey Vietri, Ashish V. Joshi, Alexandra I. Barsdorf & Jack Mardekian. (2014) Prescription Opioid Abuse and Tampering in the United States: Results of a Self-Report Survey. Pain Medicine 15:12, pages 2064-2074.
Crossref
Crossref
N. Jedinger, J. Khinast & E. Roblegg. (2014) The design of controlled-release formulations resistant to alcohol-induced dose dumping – A review. European Journal of Pharmaceutics and Biopharmaceutics 87:2, pages 217-226.
Crossref
Crossref
Louis Alexander, Richard O. Mannion, Brianne Weingarten, Richard J. Fanelli & Gary L. Stiles. (2014) Development and impact of prescription opioid abuse deterrent formulation technologies. Drug and Alcohol Dependence 138, pages 1-6.
Crossref
Crossref
Dennis C. Turk, Elizabeth J. Dansie, Hilary D. Wilson, Bruce Moskovitz & Myoung Kim. (2014) Physicians' Beliefs and Likelihood of Prescribing Opioid Tamper-Resistant Formulations for Chronic Noncancer Pain Patients. Pain Medicine 15:4, pages 625-636.
Crossref
Crossref
Bing Cai, Håkan Engqvist & Susanne Bredenberg. (2014) Evaluation of the resistance of a geopolymer-based drug delivery system to tampering. International Journal of Pharmaceutics 465:1-2, pages 169-174.
Crossref
Crossref
Sindhuri Maddineni, Sunil Kumar Battu, Joe Morott, Majumdar Soumyajit & Michael A Repka. (2014) Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments. Journal of Pharmacy and Pharmacology 66:2, pages 309-322.
Crossref
Crossref
Lawrence M. Martin & Ali R. Rajabi-Siahboomi. 2014. Hydrophilic Matrix Tablets for Oral Controlled Release. Hydrophilic Matrix Tablets for Oral Controlled Release
123
141
.
Frank E. Casty, Matthew S. Wieman & Neil Shusterman. (2013) Current Topics in Opioid Therapy for Pain Management: Addressing the Problem of Abuse. Clinical Drug Investigation 33:7, pages 459-468.
Crossref
Crossref
M.K. Romach, K.A. Schoedel & E.M. Sellers. (2013) Update on tamper-resistant drug formulations. Drug and Alcohol Dependence 130:1-3, pages 13-23.
Crossref
Crossref
Sampada B. Upadhye & Ali R. Rajabi-Siahboomi. 2013. Melt Extrusion. Melt Extrusion
145
158
.
Sejal Shah & Michael A. Repka. 2013. Melt Extrusion. Melt Extrusion
3
46
.
Joseph V. Pergolizzi. (2012) Treatment of Chronic Pain in Older People: Evidence-Based Choice of Strong-Acting Opioids. Drugs & Aging 29:12, pages 993-995.
Crossref
Crossref